In December 2021, XIFIN expanded into the pharmacy market with the acquisition of informatics firm OmniSYS. XIFIN is a leading consultancy for lab revenue cycle improvement.
- See press release here.
- See coverage at HIT Consultant here.
- The story was featured in the January 10, 2022, Dark Report (subscription).
- In other news, XIFIN expanded 54% in CY2021 to 800 employees, with both East and West coast offices. Here.
I've clipped the press release descriptions of both XIFIN and OmniSYS below the break.
OmniSYS is a technology company with 25+ years of experience working with pharmacies, payers, providers and pharmaceutical manufacturers. We leverage this unique market insight along with our pharmacy workflow expertise to deliver valuable solutions that help pharmacies thrive in the changing pharmacy landscape. Our solutions help pharmacies engage patients, grow clinical services and improve financial performance. OmniSYS currently serves over 30,000 pharmacies, connects to hundreds of payers and touches millions of patient lives. You can visit us at omnisys.com, or follow us on LinkedIn and Twitter.
XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company's cloud-based technology facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement of care. The company provides cross-specialty industry analytics including its Lab Volume Index which provides a measurement of laboratory testing volumes across the US. Its synthesis of diagnostic data enables comparisons of hospital, genetics, pathology, routine lab, COVID-19 and antibody testing across key segments. To learn more, visit www.XIFIN.com, follow XIFIN on Twitter and LinkedIn, or subscribe to the XIFIN blog.
